MedChemExpress LLC published a study finding that mutant KRAS can reshape the tumor microbiome and enrich Bacteroides acidifaciens.
Published
Signal category
Research & Knowledge
Quote
“A recent study found that mutant KRAS can reshape the tumor microbiome and enrich Bacteroides acidifaciens.”
— MedChemExpress LLC team
Company
MedChemExpress LLC
Master of Bioactive Molecules.
- Industry
- Biotechnology Research
- Location
- Monmouth Junction, US
- Company size
- 140 employees
MedChemExpress (MCE) is a leading global supplier of life science reagents, dedicated to providing innovative solutions for scientific research and drug development. We offer a comprehensive range of high-quality active molecules, including inhibitors, compound libraries, recombinant proteins, antibodies, and more, positioning itself as a leading global supplier of research chemicals and bioactive compounds. Headquartered in New Jersey, USA, MCE has established multiple R&D, production, and logistics centers worldwide. With a team of seasoned experts, MCE has built an end-to-end service system, encompassing services such as HNMR data analysis, bioactivity evaluation, technical consultation, and after-sales support. Backed by stringent management systems and quality control standards, MCE delivers efficient, precise, and reliable services to over 15,000 research institutions worldwide. Committed to driving innovation in drug discovery, MCE is your trusted long-term partner for scientific exploration and pharmaceutical research. https://linktr.ee/MedChemExpress
Founded 2009